# US 2008/0306262 A1 · Novel Compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306262 A1
- Document ID: US20080306262A1
- Status: Published application
- Kind: A1
- Application number: 11/965,486
- Filed: 2007-12-27
- Published: 2008-12-11
- Earliest claimed: 2002-09-20
- Assignees: AstraZeneca AB, a Swedish corporation
- Inventors: Roger Victor Bonnert
- Web page: https://patentgrep.com/patent/US20080306262A1

## CPC

- C07D 513/04: Ortho-condensed systems
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/02: Nasal agents, e.g. decongestants
- A61P 11/06: Antiasthmatics
- A61P 11/16: Central respiratory analeptics
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 19/10: for osteoporosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 37/02: Immunomodulators
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.

## Claims

### Claim 1

A monosodium salt of the compound of formula (I):

### Claim 2 (depends on 1)

A process for the preparation of a compound of formula (I) of claim 1, which comprises reaction of a compound of formula (II):
where R is C1-6 alkyl with an acid,
and thereafter forming a monosodium salt.
